The Journal of Pharmacology and Experimental Therapeutics has retracted this article. In September 2024, Athira Pharmas LIFT-AD trial of fosgonimetona clinical derivative of Dihexafailed to meet primary and secondary endpoints in 312 mild-to-moderate Alzheimers patients
Compounded options exist legally because of the official FDA shortage list, and the FDA's position on them has been evolving
Protein S-palmitoylation is markedly inhibited by 4-alkyl ether lipophilic derivatives of EGCG, the major green tea polyphenol: In vitro and in silico studies
Santa Cruz, California: American Herbal Pharmacopoeia
Complications Most studies in the literature reported no local adverse events after PRP injection such as knee pain, erythema, or locking
All prescription weight loss medication has approval from the FDA and is typically safe to take